Children’s Hospital Los Angeles is offering families an opportunity to eliminate the danger of unwanted medications in their home by disposing of their unwanted pills safely, responsibly and permanently.
Drug effects have dominated the national conversation about psychedelics for medical treatment, but a new study suggests that when it comes to reducing depression with psychedelic-assisted therapy, what matters most is a strong relationship between the therapist and study participant.
Opioid dependence in Scotland remains high but largely stable, according to a new University of Bristol-led analysis published in Addiction today [18 April] and by Public Health Scotland. The study is the first to estimate the number of people dependent on opioid drugs (such as heroin), and who are in or could benefit from drug treatment, among Scotland’s population since 2015/2016 estimates were published.
Rutgers Health researchers publish largest study on outcomes associated with hospital-based peer support programs after opioid overdose
Himelhoch comes to UChicago from the University of Kentucky, where his public health research has focused on interventions for those with HIV and substance use disorders and cancer control.
Treatment for lung condition could help patients with sickle cell disease control complications from hypertension and kidney damage
A new CU Boulder study sheds light on how genes associated with smoking work in conjunction with the rest of the genome, paving the way for more personalized approaches to help people kick the habit.
A Johns Hopkins Medicine-led research team has added to evidence that a chemical found naturally in cannabis (also known as marijuana) can — in the right amounts — lessen the anxiety-inducing effects of tetrahydrocannabinol (THC), the primary psychoactive sister chemical found in cannabis.
A new analysis by researchers at UCLA Health found that mortality rates of middle-aged Black Americans caused by the “deaths of despair” -- suicide, drug overdose and alcoholic liver disease – surpassed the rate of white Americans in 2022.
Results of a study shows the opioid crisis is not just about the drugs used; it is also about the ones that are not used. The findings, emphasizing the importance of safe drug disposal, are timely as the next National Prescription Drug Take Back Day, sponsored by the US Drug Enforcement Agency (DEA), approaches on April 27, 2024.
Polymer-based hydrogels are used to treat skin ailments and in tissue engineering because of their ability to retain water, deliver drugs into wounds, and biodegrade. However, they are complicated to manufacture and not very resilient to external forces like rubbing against clothing, sheets, or wound dressings.
Researchers from the University of Chicago had a paper published in JAMA that dug into data on why so few mental health and substance use facilities opted not to use long-acting injectable buprenorphine to help people with opioid use disorder.
Researchers take a closer look at both the potential benefits and risks of acetaminophen, NSAIDs such as ibuprofen, as well as aspirin for the selection of OTC drugs to treat mild symptoms of COVID-19.
Physician assistants (PAs) and nurse practitioners (NPs) are at the heart of patient care in Appalachia, often taking the lead in managing pain and prescribing medications. Their role is significant, but their training in opioid management falls short when compared to their physician counterparts.
Taking “study drugs” like Adderall without a diagnosis is not only dangerous in itself, but can lead to other drug use and a decline in mental health, according to new research from Binghamton University, State University of New York.
Short-acting opioids managed pain as well with less nausea and fewer rehab center stays, Rutgers Health researchers find.
Counties could save money and keep more people out of jail by improving access to community-based mental health and substance use disorder services, according to a study led by a Michigan State University College of Human Medicine professor.
Researchers have developed a new generation of high-performance DNA aptamers and highly accurate drug sensors for cocaine and other opioids. The sensors are drug specific and can detect trace amounts of fentanyl, heroin, and cocaine – even when these drugs are mixed with other drugs or with cutting agents and adulterants such as caffeine, sugar, or procaine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right